Commonwealth Equity Services, LLC Biodesix Inc Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$1.35 - $2.12 $540 - $848
400 Added 2.51%
16,313 $23,000
Q4 2023

Feb 06, 2024
SELL
$1.2 - $2.13 $13,182 - $23,398
-10,985 Reduced 40.84%
15,913 $29,000
Q3 2023

Oct 23, 2023
BUY
$1.04 - $1.74 $3,987 - $6,671
3,834 Added 16.62%
26,898 $44,000
Q2 2023

Aug 10, 2023
BUY
$1.12 - $1.88 $13,972 - $23,453
12,475 Added 117.81%
23,064 $28,000
Q1 2023

May 11, 2023
BUY
$1.52 - $2.5 $16,095 - $26,472
10,589 New
10,589 $19,000

Others Institutions Holding BDSX

# of Institutions
58
Shares Held
62.3M
Call Options Held
2.6K
Put Options Held
10.1K
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $55.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email